SSKI- potassium iodide solution

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

Potassium Iodide (UNII: 1C4QK22F9J) (Iodide Ion - UNII:09G4I6V86Q)

Pieejams no:

Avondale Pharmaceuticals, LLC

Ievadīšanas:

ORAL

Receptes veids:

PRESCRIPTION DRUG

Ārstēšanas norādes:

SSKI® (potassium iodide oral solution, USP) is for use as an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem, including bronchial asthma, bronchitis and pulmonary emphysema. Contraindicated in patients with a known sensitivity to iodides.

Produktu pārskats:

SSKI® (potassium iodide oral solution, USP) is supplied in 1 fluid ounce (30 ml) bottles (NDC 71740-112-30) with a calibrated dropper marked to deliver 0.3 ml (300 mg) and 0.6 ml (600 mg); and 8 fluid ounce (237 ml) bottles (NDC 71740-112-08). Inactive ingredient: Sodium thiosulfate as a preservative. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Keep tightly closed and protected from light. For the 237mL bottle, dispense in tight, light-resistant containers with child-resistant closures. For the 30mL bottle, place the child-resistant cap back on the amber glass bottle after using the clear plastic dropper for dispensing. Notice: When exposed to cold temperatures, crystallization may occur, but on warming and shaking, the crystals will redissolve. If the solution turns brownish-yellow in color, it should be discarded.

Autorizācija statuss:

unapproved drug other

Produkta apraksts

SSKI- POTASSIUM IODIDE SOLUTION
AVONDALE PHARMACEUTICALS, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
SSKI
POTASSIUM IODIDE ORAL SOLUTION, USP (SATURATED)
1 G/ML
RX ONLY
DESCRIPTION
SSKI
(potassium iodide oral solution, USP) is a saturated solution of
potassium iodide
containing 1 gram of potassium iodide per mL.
CLINICAL PHARMACOLOGY
Potassium iodide is thought to act as an expectorant by increasing
respiratory tract
secretions and thereby decreasing the viscosity of mucus.
INDICATIONS AND USAGE
SSKI
(potassium iodide oral solution, USP) is for use as an expectorant in
the
symptomatic treatment of chronic pulmonary diseases where tenacious
mucus
complicates the problem, including bronchial asthma, bronchitis and
pulmonary
emphysema.
CONTRAINDICATIONS
Contraindicated in patients with a known sensitivity to iodides.
WARNINGS
Potassium iodide can cause fetal harm, abnormal thyroid function, and
goiter when
administered to a pregnant woman. Because of the possible development
of fetal goiter,
if the drug is used during pregnancy or if the patient becomes
pregnant during therapy,
apprise the patient of the potential hazard.
PRECAUTIONS
GENERAL
In some patients, prolonged use of iodides can lead to hypothyroidism.
Iodides should
be used with caution in patients having Addison's disease, cardiac
disease,
®
®
®
hyperthyroidism, myotonia congenita, tuberculosis, acute bronchitis,
or renal function
impairment.
DRUG INTERACTIONS
Concurrent use with lithium or antithyroid drugs may potentiate the
hypothyroid and
goitrogenic effects of these medications. Concurrent use with
potassium-containing
medications, potassium-sparing diuretics and angiotensin-converting
enzyme inhibitors
(ACE inhibitors) may result in hyperkalemia and cardiac arrhythmias or
cardiac arrest.
DRUG/LABORATORY TEST INTERACTIONS
Thyroid function tests may be altered by iodide.
PREGNANCY
see "Warni